RESUMO
BACKGROUND: Vitiligo is an acquired pigmentary cutaneous disease, characterised by the progressive loss of melanocytes, resulting in hypopigmented skin areas which progressively become amelanotic. Classically, vitiligo treatments are unsatisfactory and challenging. Despite the continuous introduction of new therapies, phototherapy is still the mainstay for vitiligo repigmentation. AIM: The aim of this multicenter observational retrospective study was to evaluate the efficacy and safety of the nb - UVB micro - phototherapy (BIOSKIN EVOLUTION®), used alone or in associations with an oral Janus kinase inhibitor (Tofacitinib citrate), in the treatment of stable or active forms of localised vitiligo. MATERIAL AND METHODS: Fifty eight patients had been treated with n-UVB micro-photootherapy (Group A); 9 patients had been treated with phototherapy plus Tofacitinb citrate (Group B). RESULTS: Among Group A, 42 patients (72%) obtained a re-pigmentation rate higher than 75%, with a medium value of 77%. 11 patients (19%) achieved a marked improvement of the clinical findings with a repigmentation rate between 50-75%; 4 patients (8%) showed a moderate response with a lesional repigmentation of 25-50%. Only one patient (1%) had a poor response to the phototherapeutic treatment. CONCLUSION: Nb - UVB micro-focused phototherapy is one of the most effective therapeutic options for vitiligo treatment. The association of micro-focused phototherapy to Tofacitinib citrate seems to provide better clinical results in term of repigmentation rate.
RESUMO
Vitiligo is depigmenting disorder of the skin and mucous membranes but despite various therapeutic options, complete and satisfactory treatment of vitiligo still remains a challenge. Therapeutic success also varies depending on the localization of lesions; hands and bony prominents are considered to be resistant to treatment. We investigated feasibility of treating resistant bilateral symmetrical vitiligo vulgaris and acrofacialis lesions with combination of narrowband UVB and topical prostaglandins (0.005% latanoprost solution) with or without Dermaroller 0.5 mm needle length-assisted microneedling. Frequency of repigmentation onset was generally low (37.8%) and pronounced repigmentation was infrequently seen (26-50% repigmentation in 20.8%, and >50% repigmentation in only 8.8% of repigmenting lesions). Our study, however, showed that latanoprost can be used in combination with NB-UVB phototherapy to induce repigmentation in some vitiligo lesions in resistant-to-treatment location, while addition of skin microneedling seems not to improve the treatment outcome and possibly needs modification.
Assuntos
Fármacos Dermatológicos/administração & dosagem , Agulhas , Prostaglandinas F Sintéticas/administração & dosagem , Pigmentação da Pele/efeitos dos fármacos , Pigmentação da Pele/efeitos da radiação , Terapia Ultravioleta , Vitiligo/terapia , Adolescente , Adulto , Terapia Combinada , Croácia , Desenho de Equipamento , Estudos de Viabilidade , Feminino , Humanos , Latanoprosta , Masculino , Pessoa de Meia-Idade , Miniaturização , Estudos Prospectivos , Fatores de Tempo , Resultado do Tratamento , Terapia Ultravioleta/efeitos adversos , Vitiligo/diagnóstico , Vitiligo/fisiopatologia , Adulto JovemRESUMO
Vitiligo, depigmenting disorder of the skin and mucous membranes, affects up to 1% of the population worldwide. It is classified into four major types: segmental, non-segmental, mixed, and unclassified type. Non-segmental vitiligo refers to non-dermatomal distribution of lesions, while dermatomal distribution of lesions is present in patients with segmental vitiligo. Segmental vitiligo can also follow Blaschko lines - pathways of epidermal cell migration and proliferation during the development of the fetus. Here, we present patient with segmental and non-segmental vitiligo following Blaschko lines with excellent therapeutic response to combined therapy. Prior to our report, a case of segmental and non-segmental vitiligo followed by Blaschko lines was never described, therefore we suggest the term "mixed vitiligo of Blaschko lines" to describe this entity. This is also a rare case in which 90% repigmentation was achieved in patient with segmental and nonsegmental vitiligo following Blaschko lines in only 2 months of combined therapy.
Assuntos
Vitiligo/terapia , Adulto , Antioxidantes/uso terapêutico , Clobetasol/uso terapêutico , Terapia Combinada , Feminino , Humanos , Fototerapia , Vitiligo/patologiaRESUMO
Chronic pruritus is a common dermatological condition affecting 10-13% of the general population. UVB phototherapy has been demonstrated to be effective in relieving the symptoms of pruritus. However, phototherapy is rarely administered because the treatment is time-consuming and expensive, when compared to other topical drugs. In previous works, it has been reported that a topical cream, which selectively filters solar UVB can be used as a convenient alternative to traditional phototherapy. Here, we report the results of a pilot study aimed at assessing the effectiveness of the cream for treating pruritus. Seven patients with pruritus symptoms were included in the study. After 3 months of treatment (3 sessions per week), all patients noted improvement in pruritus symptoms. These preliminary results demonstrate that the novel topical cream could provide a convenient, low cost treatment for chronic pruritus patients.
Assuntos
Prurido/terapia , Terapia Ultravioleta/métodos , Administração Cutânea , Adulto , Doença Crônica , Feminino , Seguimentos , Humanos , Projetos Piloto , Prurido/patologia , Creme para a Pele , Resultado do TratamentoRESUMO
Biosorption of uranium from nuclear waste liquids and contaminated surface waters and soils has recently attracted special interest. However, the detailed mechanism of uranium uptake by plants is not well understood. The aim of this work is to investigate the role of cell wall components of the freshwater alga Chara fragilis in uranium sequestration from its solution. Three types of algae preparations: extract of cell wall polysaccharides, dried and live algae were subjected to uranium solutions of different concentration and pH. FTIR and X-ray diffraction were used to assess both potential binding sites and the form of the uranyl sequestered by algae. Sorption of uranium by live and dry algae shows remarkable differences both in terms of overall uptake and mechanisms involved. All experiments are consistent with the conclusion that coprecipitation of uranyl species with CaCO3 is the major binding mechanism in uranium sequestration by Chara fragilis, while the direct exchange of Ca2+ with UO22+ has a minor role. Live algae are twice as efficient in sequestering uranium from solution than dried ones due to the formation of different crystalline forms such as aragonite and rutherfordine forming in live algae in the presence of the uranyl species in solution. It therefore appears that metabolic processes such as photosynthesis, most likely through the regulation of pH, play a key role in the uranium uptake by plants. Further understanding of the complex mechanism of metabolic control of the uranium uptake by plants is needed before the planning of bioremediation of this element.